Work

Mucus-targeting therapies of defective mucus clearance for cystic fibrosis: A short review

Year: 2022

Type: review

Source: Current Opinion in Pharmacology

DOI: 10.1016/j.coph.2022.102248

Authors: Miriam Frankenthal Figueira, Carla M.P. Ribeiro, Brian Button

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cystic Fibrosis Foundation, National Institutes of Health, University of North Carolina at Chapel Hill, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Pre-Clinical Evaluation of IRE1beta as a Novel Therapeutic Target for Cystic Fibrosis Airway Mucus Production, G4136388919, G4844118799, G5456327337, G6365659912, G648678753, G6802975429, The role of mucus and pulmonary surface interactions in lung defense, G8947767349, UNC Cystic Fibrosis Research and Translation Core Center

OpenAlex ID: W4281771458

FWCI: 0.606

Cites: 97

Cited by: 19

Related to: 10